IP Library Assignment 037393/0995
Patent Assignment
Reel/Frame 037393/0995

Change of Address

Recorded: 2015-12-28 Pages: 2
Assignor
NEURON SYSTEMS, INC.
Executed: 2010-05-11
Assignee
NEURON SYSTEMS, INC.
15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON, MASSACHUSETTS, 01803
Covered Property (1)
Compositions and Methods of Treating Retinal Disease
Patent: 9,265,759 →
Application: 14/581,462 →
Publication: US 2015/0209345
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Aug 28, 2015
From: ALDEXA THERAPEUTICS, INC.
To: ALDEYRA THERAPEUTICS, INC.
Reel/Frame 036504/0756 →
Assignment of Assignor's Interest Dec 28, 2015
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 037365/0630 →
Change of Name Dec 28, 2015
From: NEURON SYSTEMS, INC.
To: ALDEXA THERAPEUTICS, INC.
Reel/Frame 037394/0030 →
Security Interest Dec 7, 2016
From: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC.)
To: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
Reel/Frame 040589/0196 →
Release of Security Interest Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →